18 Oct 2018

The MHRA On CBD/Hemp Products And Its Relationship With Trade Associations

This is an email from the MHRA to a CBD/Hemp supplier which name is redacted. It clearly sets out the MHRA's position regarding the Cannabis Trades Association, its 'Cannabis Products Directive' proposal and how anyone is able to obtain advice from the MHRA without having to join any trade association. It also explains how medical claims may only be made about a CBD product if it has the required licence known as a marketing authorisation. This is authoritative guidance from the...

12 Oct 2018

Will I Be Able To Get Cannabis Prescribed On The NHS?

With the publication of new regulations yesterday, it is now clear how cannabis will be available on the NHS starting on 1st November 2018. Only consultants will be able to prescribe cannabis and it will be entirely up to each consultant to make a decision about individual patients. The definition of cannabis-derived medicinal products is sufficently wide that both oils and herbal cannabis manufactured to GMP (Good Manufacturing Practice) standards will be available. There is very little explanation included in the regulations...

13 Sep 2018

CLEAR Advises Department of Health and MHRA on Definition of Cannabis-Derived Medicinal Products.

Last week, CLEAR was invited to participate in a teleconference with representatives of the Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA). This followed our written submissions made over the last few weeks. The teleconference included two representatives from each party. The DHSC was represented by the Medicines Pharmacy and Industry section. The MHRA was represented by the Licensing Division. CLEAR has now submitted a summary of all the advice offered which is reproduced...

26 Jul 2018

The Definition Of A Cannabis-Derived Medicinal Product Must Include Standardised Herbal Cannabis Or Sajid Javid’s Reform Will Fail.

Bedrocan, the Netherlands government's official producer, grows cannabis in which the cannabinoid and terpene content is standardised and consistent. It does this by very careful cultivation techniques which include clonal propagation, continuous analysis and gamma irradiation to eliminate contamination with potentially harmful microbes. Its production facility is Good Manufacturing Practice (GMP) certified. With the exception of Sativex, which NICE has declared as not cost effective, the Bedrocan range offers the only medicinal cannabis products which could be readily available in the...

05 Jul 2018

An ‘Expert Panel’ On Medicinal Cannabis Without A Single Expert On It?

To be fair, the members of the expert panel are hardly a surprise. It's the medical establishment writ large. The chairman, Dr John McBride, was, according to Charlotte Caldwell, "instrumental" in stopping Billy's medicine being prescribed, despite the original prescription coming from a consultant neurologist specialising in paediatric epilepsy. A government which has denied any medicinal value in cannabis for nearly 50 years needs 'cover' for its long...

04 Jul 2018

Dame Sally’s Caution On “Grown Cannabis” Does Not Bode Well For Access To Herbal Cannabis As Medicine.

Great news all round! Professor Dame Sally Davies has, within a matter of days concluded that cannabis does have medicinal value and needs to be removed from schedule 1. No surprise really as the evidence is, as Dame Sally says, "overwhelming". The simple fact is that our government has been deliberately ignoring it for years. However, reading Dame Sally's report yesterday I was immediately struck by her use of the term "grown cannabis" in a disparaging sense. I’m tempted to ask...

30 Jun 2018

A Quick, Easy Guide to The New UK Arrangements For Access To Cannabis As Medicine.

There's already an awful lot of misunderstanding over the arrangements just introduced for medicinal cannabis and there's no need for it because, to be fair, the government has been very clear. There is an interim procedure which will be very, very difficult for most to achieve. You must have very strong support from your doctor and they, together with your local NHS Trust, must be prepared to put in a lot of work, form-filling and pay some substantial licensing fees. It's...

16 May 2018

Let’s Nail the Home Office’s Latest Smokescreen About Medical Cannabis

As the evidence and support for legal access to cannabis for medical use grows, so the Home Office adjusts and reframes its arguments in denial. This should come as no surprise. The 'hostile environment' revealed by the Windrush scandal runs through the Home Office like a stick of rock. The culture of this department is defined by Theresa May and it reflects her character and personality. It is secretive, demands total control and micro management of everything it touches and whenever...

03 May 2018

There Was Grenfell, Then The Windrush Generation And Now Theresa May Fiddles While Alfie Dingley Faces Death

When Will This Tyrant Be Overthrown?   The campaign to save Alfie Dingley's life looked to have succeeded on 20th March when 108 MPs met Alfie and family at Parliament. That same day, accompanied by Sir Patrick Stewart, a petition of over 370,000 signatures was delivered to Downing Street and Theresa May herself met with the family and encouraged them that everything possible would be done to help. Originally, the Home Office were suggesting that they might issue a licence to allow...

17 Apr 2018

The Facts About CBD In The UK. April 2018.

This article is an update to 'The Facts About CBD In The UK. December 2016.' The past three years have seen a true phenomenon develop around the cannabis law reform movement which has quickly crossed into mainstream society, commerce and general awareness. It's the explosion of the CBD market, a trade that has grown from zero to £50 million per annum in the UK in this very short period. There has been a great deal of nonsense published about the market, the...